Published

Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Clinical Pharmacokinetics
Date: 2025-01-01
Source: Crossref
DOI: 10.1007/s40262-024-01454-4
PubMed: 39812743

Authors

Otto Marije E.van der Heijden Katelijne V.Schoones Jan W.van Esdonk Michiel J.Borghans Laura G. J. M.Jacobs Gabriel E.van Hasselt J. G. Coen

Watch author

Derived topics and classifications

psilocybin psilocin Pharmacology Systematic Review Review Article Systematic Review

Citation graph

38 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

10.1016/j.euroneuro.2023.07.011 10.1038/s41573-022-00421-7 10.1126/science.adf0435 10.1038/s41593-022-01177-4 10.1038/s41380-023-02274-x 10.1038/d41586-021-00187-9 10.1038/s41386-023-01648-7 10.1001/jama.2023.14530 10.1016/j.eclinm.2022.101809 10.1080/03602532.2016.1278228 10.1016/0006-2952(61)90124-1 10.1016/0041-008x(62)90102-3

Indexed papers citing this DOI

Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry2026-06-04 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01

Related papers

A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic CancerClinicalTrials.gov · 2025-11-05 A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic CancerClinicalTrials.gov · 2025-10-14 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-07-31 Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)ClinicalTrials.gov · 2026-05-14 The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)ClinicalTrials.gov · 2025-07-23